These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7920257)

  • 41. Proteolytic excision and in situ cyclization of a bioactive loop from an REI-VL presentation scaffold.
    Helms LR; Wetzel R
    Protein Sci; 1994 Jul; 3(7):1108-13. PubMed ID: 7920257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A paradigm for drug discovery using a conformation from the crystal structure of a presentation scaffold.
    Zhao B; Helms LR; DesJarlais RL; Abdel-Meguid SS; Wetzel R
    Nat Struct Biol; 1995 Dec; 2(12):1131-7. PubMed ID: 8846226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of hybrid peptide analogs to receptor recognition domains on alpha- and gamma-chains of human fibrinogen on fibrinogen binding to platelets.
    Mohri H; Ohkubo T
    Thromb Haemost; 1993 May; 69(5):490-5. PubMed ID: 8322271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel cyclization chemistry especially suited for biologically derived, unprotected peptides.
    Wood SJ; Wetzel R
    Int J Pept Protein Res; 1992 Jun; 39(6):533-9. PubMed ID: 1399273
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regeneration of native secondary and tertiary structures by air oxidation of reduced ribonuclease.
    WHITE FH
    J Biol Chem; 1961 May; 236():1353-60. PubMed ID: 13784818
    [No Abstract]   [Full Text] [Related]  

  • 46. On the isolation, characterisation, and crystallisation of a human Bence-Jones protein of kappa type.
    Palm WH
    FEBS Lett; 1970 Sep; 10(1):46-48. PubMed ID: 11945353
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural and functional analyses of the Arg-Gly-Asp sequence introduced into human lysozyme.
    Yamada T; Matsushima M; Inaka K; Ohkubo T; Uyeda A; Maeda T; Titani K; Sekiguchi K; Kikuchi M
    J Biol Chem; 1993 May; 268(14):10588-92. PubMed ID: 8486712
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simplification of high-energy collision spectra of peptides by amino-terminal derivatization.
    Stults JT; Lai J; McCune S; Wetzel R
    Anal Chem; 1993 Jul; 65(13):1703-8. PubMed ID: 8368523
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Strong inhibition of fibrinogen binding to platelet receptor alpha IIb beta 3 by RGD sequences installed into a presentation scaffold.
    Lee G; Chan W; Hurle MR; DesJarlais RL; Watson F; Sathe GM; Wetzel R
    Protein Eng; 1993 Sep; 6(7):745-54. PubMed ID: 8248098
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of conformationally constrained adhesion peptide in an antibody CDR loop and inhibition of natural killer cell cytotoxic activity by an antibody antigenized with the RGD motif.
    Zanetti M; Filaci G; Lee RH; del Guercio P; Rossi F; Bacchetta R; Stevenson F; Barnaba V; Billetta R
    EMBO J; 1993 Nov; 12(11):4375-84. PubMed ID: 8223447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cassette mutagenesis: an efficient method for generation of multiple mutations at defined sites.
    Wells JA; Vasser M; Powers DB
    Gene; 1985; 34(2-3):315-23. PubMed ID: 3891521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Automated synthesis of N-bromoacetyl-modified peptides for the preparation of synthetic peptide polymers, peptide-protein conjugates, and cyclic peptides.
    Robey FA; Fields RL
    Anal Biochem; 1989 Mar; 177(2):373-7. PubMed ID: 2729557
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel cell adhesive protein engineered by insertion of the Arg-Gly-Asp-Ser tetrapeptide.
    Maeda T; Oyama R; Ichihara-Tanaka K; Kimizuka F; Kato I; Titani K; Sekiguchi K
    J Biol Chem; 1989 Sep; 264(26):15165-8. PubMed ID: 2549054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction of integrins alpha v beta 3 and glycoprotein IIb-IIIa with fibrinogen. Differential peptide recognition accounts for distinct binding sites.
    Smith JW; Ruggeri ZM; Kunicki TJ; Cheresh DA
    J Biol Chem; 1990 Jul; 265(21):12267-71. PubMed ID: 2373693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors.
    Dennis MS; Henzel WJ; Pitti RM; Lipari MT; Napier MA; Deisher TA; Bunting S; Lazarus RA
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2471-5. PubMed ID: 2320569
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Introduction of guest peptides into Escherichia coli alkaline phosphatase. Excision and purification of a dynorphin analogue from an active chimeric protein.
    Freimuth PI; Taylor JW; Kaiser ET
    J Biol Chem; 1990 Jan; 265(2):896-901. PubMed ID: 1967250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of an exogenous peptide epitope genetically engineered in the variable domain of an immunoglobulin: implications for antibody and peptide folding.
    Sollazzo M; Billetta R; Zanetti M
    Protein Eng; 1990 Dec; 4(2):215-20. PubMed ID: 1706095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel method for the incorporation of glycoprotein-derived oligosaccharides into neoglycopeptides.
    Wood SJ; Wetzel R
    Bioconjug Chem; 1992; 3(5):391-6. PubMed ID: 1420438
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.